Glutamate receptors in pediatric tumors of the central nervous system

Cancer Biology and Therapy

Volumn 9, Issue 6, 2010, Pages 455-468

  Brocke, Katja S ^a   Staufner, Christian ^a   Luksch, Hella ^a   Geiger, Kathrin D ^a   Stepulak, Andrzej ^b,c   Marzahn, Jenny ^a   Schackert, Gabriele ^d   Temme, Achim ^d   Ikonomidou, Chrysanthy ^a,e  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^c MSWia ^*  (Poland)

^d UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^e UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Brain; Cancer; Glutamate receptor; Immunohistochemistry; PCR

Indexed keywords

GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR 1; GLUTAMATE RECEPTOR 4; GLUTAMATE RECEPTOR 5; GLUTAMATE RECEPTOR 7; GLUTAMATE RECEPTOR ANTAGONIST; GLUTAMIC ACID; KAINIC ACID RECEPTOR; METABOTROPIC RECEPTOR 1; METABOTROPIC RECEPTOR 2; METABOTROPIC RECEPTOR 3; METABOTROPIC RECEPTOR 4; METABOTROPIC RECEPTOR 5; METABOTROPIC RECEPTOR 6; METABOTROPIC RECEPTOR 7; METABOTROPIC RECEPTOR 8;

ADOLESCENT; ARTICLE; ASTROCYTOMA; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; EPENDYMOMA; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MEDULLOBLASTOMA; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH;

EID: 77953726117     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.9.6.10898     Document Type: Article

References (51)

1. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007; 14:97-109. (Pubitemid 47103521)
2. Kaatsch P, Rickert CH, Kühl J, Schuz J, Michaelis J. Population-based epidemiologic data on brain tumors in German children. Cancer 2001; 92:3155-64. (Pubitemid 33136212)
3. Partap S, Fisher PG. Update on new treatments and developments in childhood brain tumors. Curr Opin Pediatr 2007; 19:670-4. (Pubitemid 350145235)
4. Grimmer MR, Weiss WA. Childhood tumors of the nervous system as disorders of normal development. Curr Opin Pediatr 2006; 18:634-8.
5. Alcantara Llaguno S, Chen J, Kwon CH, Jackson EL, Li Y, Burns DK, et al. Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model. Cancer Cell 2009; 15:45-56.
6. Ikonomidou C, Bosch F, Miksa M, Bittigau P, Vöckler J, Dikranian K, et al. Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 1999; 283:70-4. (Pubitemid 29044848)
7. Komuro H, Rakic P. Modulation of neuronal migration by NMDA receptors. Science 1993; 260:95-7. (Pubitemid 23122752)
8. Rzeski W, Turski L, Ikonomidou C. Glutamate antagonists limit tumor growth. Proc Natl Acad Sci USA 2001; 98:6372-7. (Pubitemid 32488244)
9. Skerry TM, Genever PG. Glutamate signalling in nonneuronal tissues. Trends Pharmacol Sci 2001; 22:174-81.
10. Ye ZC, Sontheimer H. Glioma cells release excitotoxic concentrations of glutamate. Cancer Res 1999; 59:4383-91. (Pubitemid 29418758)
11. Takano T, Lin JH, Arcuino G, Gao O, Yang J, Nedergaard M. Glutamate release promotes growth of malignant gliomas. Nat Med 2001; 7:1010-5. (Pubitemid 32937380)
12. Ishiuchi S, Tsuzuki K, Yoshida Y, Yamada N, Hagimura N, Okado H, et al. Blockage of Ca(2+)-permeable AMPA receptor suppresses migration and induces apoptosis in human glioblastoma cells. Nat Med 2002; 8:971-8.
13. Lyons SA, Chung WJ, Weaver AK, Oqunrinu T, Sontheimer H. Autocrine glutamate signaling promotes glioma cell invasion. Cancer Res 2007; 67:9463-71. (Pubitemid 47535936)
14. Iacovelli L, Arcella A, Battaglia G, Pazzaglia S, Aronica E, Spinsanti P, et al. Pharmacological activation of mGlu4 metabotropic glutamate receptors inhibits the growth of medulloblastomas. J Neurosci 2006; 26:8388-97. (Pubitemid 44309853)
15. Nicoletti F, Arcella A, Iacovelli L, Battaglia G, Giangaspero F, Melchiorri D. Metabotropic glutamate receptors: new targets for the control of tumor growth? Trends Pharmacol Sci 2007; 28:206-13.
16. Cull-Candy S, Brickley S, Farrant M. NMDA receptor subunits: diversity, development and disease. Curr Opin Neurobiol 2001; 11:327-35. (Pubitemid 32524098)
17. Hollmann M, Heinemann S. Cloned glutamate receptors. Ann Rev Neurosci 1994; 17:31-108.
18. Husi H, Ward MA, Choudhary JS, Blackstock WB, Grant SG. Proteomic analysis of NMDA receptoradhesion protein signaling complexes. Nat Neurosci 2000; 3:661-9. (Pubitemid 30437200)
19. Platenik J, Kuramoto N, Yoneda Y. Molecular mechanisms associated with long-term consolidation of the NMDA signals. Life Sci 2000; 67:335-64. (Pubitemid 30413916)
20. Kemp JA, McKernan RM. NMDA receptor pathways as drug targets. Nat Neurosci 2002; 5:1039-42.
21. Hardingham GE, Bading H. The ying and yang of the NMDA receptor. Trends Neurosci 2003; 26:81-9.
22. Hansen HH, Briem T, Dzietko M, Sifringer M, Rzeski W, Zdzisinska B, et al. Mechanisms leading to disseminated apoptosis following NMDA receptor blockade in the developing rat brain. Neurobiol Dis 2004; 16:440-53. (Pubitemid 38757324)
23. Keinanen K, Wisden W, Sommer B, Werner P, Herb A, Verdoorn TA, et al. A family of AMPA-selective glutamate receptors. Science 1990; 249:556-60.
24. Madden DR. The structure and function of glutamate receptor ion channels. Nat Rev Neurosci 2002; 3:91-101. (Pubitemid 135706578)
25. Kew JN, Kemp JA. Ionotropic and metabotropic glutamate receptor structure and pharmacology. Psychopharmacology (Berl) 2005; 179:4-29. (Pubitemid 40576690)
26. Palmer CL, Cotton L, Henley JM. The molecular pharmacology and cell biology of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors. Pharmacol Rev 2005; 57:253-77. (Pubitemid 41043886)
27. Rodríguez-Moreno A, Lerma J. Kainate receptor modulation of GABA release involves a metabotropic function. Neuron 1998; 20:1211-8. (Pubitemid 28293137)
28. Rodríguez-Moreno A, Sihra TS. Presynaptic kainate receptor facilitation of glutamate release involves protein kinase A in the rat hippocampus. J Physiol 2004; 557:733-45. (Pubitemid 38961612)
29. Petralia RS, Wang YX, Niedzielski AS, Wenthold RJ. The metabotropic glutamate receptors, mGluR2 and mGluR3, show unique postsynaptic, presynaptic and glial localizations. Neuroscience 1996; 71:949-76.
30. Wroblewska B, Santi MR, Neale JH. N-acetylaspartyl glutamate activates cyclic AMP-coupled metabotropic glutamate N-acetylaspartylglutamate activates cyclic AMP-coupled metabotropic glutamate receptors in cerebellar astrocytes, receptors in cerebellar astrocytes. Glia 1998; 24:172-9.
31. Balázs R, Miller S, Romano C, de Vries A, Chun Y, Cotman CW. Metabotropic glutamate receptor mGluR5 in astrocytes: pharmacological properties and agonist regulation. J Neurochem 1997; 69:151-63. (Pubitemid 27274168)
32. Nishi M, Hinds H, Lu HP, Kawara M, Hayashi Y. Motoneuron-specific expression of NR3B, a novel NMDA-type glutamate receptor subunit that works in a dominant-negative manner. J Neurosci 2001; 21:185.
33. Nakajima Y, Iwakabe H, Akazawa C, Nawa H, Shigemoto R, Mizuno N, et al. Molecular characterization of a novel retinal metabotropic glutamate receptor mGluR6 with a high agonist selectivity for L-2-amino-4-phosphonobutyrate. J Biol Chem 1993; 268:11868-73. (Pubitemid 23168143)
34. de Groot JF, Piao Y, Lu L, Fuller GN, Yung WK. Knockdown of GluR1 expression by RNA interference inhibits glioma proliferation. J Neurooncol 2008; 88:121-33.
35. Watanabe K, Kanno T, Oshima T, Miwa H, Tashiro G, Nishizaki T. The NMDA receptor NR2A subunit regulates proliferation of MKN45 human gastric cancer cells. Biochem Biophys Res Commun 2008; 367:487-90.
36. Arcella A, Carpinelli G, Battaglia G, D'Onofrio M, Santoro F, Ngomba RT, et al. Pharmacological blockade of group II metabotropic glutamate receptors reduces the growth of glioma cells in vivo. Neuro Oncol 2005; 7:236-45. (Pubitemid 41079133)
37. Stepulak A, Sifringer M, Rzeski W, Brocke K, Gratopp A, Pohl EE, et al. AMPA antagonists inhibit the extracellular signal regulated kinase pathway and suppress cancer growth. Cancer Biol Ther 2007; 6:1908-15. (Pubitemid 351590403)
38. Stepulak A, Sifringer M, Rzeski W, Endesfelder S, Gratopp A, Pohl EE, et al. NMDA antagonist inhibits the extracellular signal-regulated kinase pathway and suppresses cancer growth. Proc Natl Acad Sci USA 2005; 102:15605-10. (Pubitemid 41528103)
39. Abdul M, Hoosein N. N-methyl-D-aspartate receptor in human prostate cancer. J Membr Biol 2005; 205:125-8. (Pubitemid 41803689)
40. Wang Y, Small DL, Stanimirovic DB, Mortey P, Durkin JP. AMPA receptor-mediated regulation of a Gi-protein in cortical neurons. Nature 1997; 389:502-4. (Pubitemid 27435326)
41. Hayashi T, Umemori H, Mishina M, Yamamoto T. The AMPA receptor interacts with and signals through the protein tyrosine kinase Lyn. Nature 1999; 397:72-6. (Pubitemid 29038251)
42. Aronica E, Yankaya B, Jansen GH, Leenstra S, van Veelen CW, Gorter JA, et al. Ionotropic and metabotropic glutamate receptor protein expression in glioneuronal tumours from patients with intractable epilepsy. Neuropathol Appl Neurobiol 2001; 27:223-7. (Pubitemid 32678675)
43. Yoshioka A, Ikegaki N, Williams M, Pleasure D. Expression of N-methyl-D-aspartate (NMDA) and non-NMDA glutamate receptor genes in neuroblastoma, medulloblastoma and other cells lines. J Neurosci Res 1996; 46:164-78. (Pubitemid 26367541)
44. Takeda M, Haga M, Yamada H, Kinoshita M, Otsuka M, Tsuboi S, et al. Ionotropic glutamate receptors expressed in human retinoblastoma Y79 cells. Neurosci Lett 2000; 294:97-100.
45. Liu JW, Kim MS, Nagpal J, Yamashita K, Poeta L, Chang X, et al. Quantitative hypermethylation of NMDAR2B in human gastric cancer. Int J Cancer 2007; 121:1994-2000. (Pubitemid 47463162)
46. Kim MS, Chang X, Nagpal JK, Yamashita K, Baek JH, Dasgupta S. The N-methyl-D-aspartate receptor type 2A is frequently methylated in human colorectal carcinoma and suppresses cell growth. Oncogene 2008; 27:2045-54. (Pubitemid 351442740)
47. Marin YE, Chen S. Involvement of metabotropic glutamate receptor 1, a G protein coupled receptor, in melanoma development. J Mol Med 2004; 82:735-49. (Pubitemid 40022267)
48. Choi SW, Park SY, Hong SP, Pai H, Choi JY, Kim SG. The expression of NMDA receptor 1 is associated with clinicopathological parameters and prognosis in the oral squamous cell carcinoma. J Oral Pathol Med 2004; 33:533-7. (Pubitemid 39318463)
49. Park SY, Lee SA, Han IH, Yoo BC, Lee SH, Park JY, et al. Clinical significance of metabotropic glutamate receptor 5 expression in oral squamous cell carcinoma. Oncol Rep 2007; 17:81-7.
50. Chang HJ, Yoo BC, Lim SB, Jeong SY, Kim WH, Park JG. Metabotropic glutamate receptor 4 expression in colorectal carcinoma and its prognostic significance. Clin Cancer Res 2005; 11:3288-95.
51. Grossman SA, Ye X, Chamberlain M, Mikkelsen T, Batchelor T, Desideri S, et al. Talampanel with standard radiation and temozolomide in patients with newly diagnosed glioblastoma: a multicenter phase II trial. J Clin Oncol 2009; 27:4155-61.